Jefferies lowers its price target from $103 to $100 on Buy-rated Humana HUM as expectations come down as suggested by selloff in shares.
Jefferies notes, "An 8% sell-off seems severe for a well-positioned company in a multi-year growth trend and that beat its guidance. Expectations got extremely heated during 1Q and had come back toward Earth since mid-January, but evidently not TO Earth. A negative PPD (of any kind) does not help. The market is pricing an accelerating rise in cost trend that is not borne out in numbers or comments."
HUM closed at $80.68 on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in